SCHEMBL6523099

SCHEMBL6523099

COc1nc2ccc(Br)cc2cc1Cc1ccccc1Br

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 5/20 0.39
CACNA1C Q13936 1/20 0.39
ADORA2A P29274 1/20 0.39
NR1I2 O75469 1/20 0.38
HTR1A P08908 1/20 0.38
HTR2A P28223 1/20 0.38
SLC6A3 Q01959 1/20 0.38
PRNP P04156 1/20 0.37
BACE1 P56817 1/20 0.36
CSNK1D P48730 1/20 0.35
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
RAB9A P51151 1/20 0.35
GRM1 Q13255 1/20 0.35
IDO1 P14902 1/20 0.35
NQO2 P16083 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18796004 0.87 PTGES (0.42) KCNH2CACNA1CNR1I2HTR1AHTR2A
SCHEMBL296886 0.85 KCNH2 (0.42) KCNH2CACNA1CNR1I2HTR1AHTR2A
SCHEMBL19354157 0.84 KCNH2 (0.44) KCNH2CACNA1CNR1I2HTR1AHTR2A
SCHEMBL28446573 0.84 PDE10A (0.39) KCNH2CACNA1CMAPTNQO2MEN1
SCHEMBL20776919 0.82 KCNH2 (0.46) KCNH2CACNA1CNR1I2HTR1AHTR2A
SCHEMBL19330300 0.82 KCNH2 (0.46) KCNH2CACNA1CHTR2ACSNK1DNPC1
SCHEMBL31125772 0.81 BACE1 (0.41) KCNH2CACNA1CNR1I2HTR1AHTR2A
SCHEMBL19354234 0.81 KCNH2 (0.47) KCNH2CACNA1CNR1I2HTR1AHTR2A
SCHEMBL19354042 0.81 KCNH2 (0.39) KCNH2CACNA1CNR1I2HTR1AHTR2A
SCHEMBL30701237 0.81 KCNH2 (0.39) KCNH2CACNA1CNR1I2HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110059948-A1 QUINOLINE, NAPHTHALENE AND CONFORMATIONALLY CONSTRAINED QUINOLINE OR NAPHTHALENE DERIVATIVES AS ANTI-MYCOBACTERIAL AGENTS THE INSTITUTE OF MOLECULAR MEDICINE (IN) 2011-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110059948-A1 QUINOLINE, NAPHTHALENE AND CONFORMATIONALLY CONSTRAINED QUINOLINE OR NAPHTHALENE DERIVATIVES AS ANTI-MYCOBACTERIAL AGENTS NQO1, NQO2, NDUFV1 KCNH2 2506/4885CACNA1C 4346/4885ADORA2A 3492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.